Acute Pulmonary Embolism in Patients with and without COVID-19.

ABSTRACT: Acute pulmonary embolism (APE) is a frequent condition in patients with COVID-19 and is associated with worse outcomes. Previous studies suggested an immunothrombosis instead of a thrombus embolism, but the precise mechanisms remain unknown. To assess the determinants and prognosis of APE during COVID-19. We retrospectively included all consecutive patients with APE confirmed by computed tomography pulmonary angiography hospitalized at Strasbourg University Hospital from 1 March to 31 May 2019 and 1 March to 31 May 2020. A comprehensive set of clinical, biological, and imaging data during hospitalization was collected. The primary outcome was transfer to the intensive care unit (ICU). APE was diagnosed in 140 patients: 59 (42.1%) with COVID-19, and 81 (57.9%) without COVID-19. A 812% reduc

SUBMITTER: Trimaille A 

PROVIDER: S-EPMC8150992 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature